{
    "clinical_study": {
        "@rank": "72379", 
        "brief_summary": {
            "textblock": "The purpose of this study is to identify the neurophysiologic indicators of cocaine or\n      methamphetamine use and withdrawal, to examine the relationship between subjects' reports of\n      depression, craving, and stimulant use, and neurophysiologic measures, and to identify\n      neurophysiologic measures which can be used to identify new treatments for stimulant\n      dependence."
        }, 
        "brief_title": "Brain Changes in Stimulant Dependent Subjects - 8", 
        "condition": "Substance-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Substance-Related Disorders"
        }, 
        "detailed_description": {
            "textblock": "By Incorporating QEEG into clinical trails, the plan is to develop physiologic markers of\n      treatment efficacy, and to aid in the identification of effective treatments."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the\n        study and sign informed consent.\n\n        Exclusion Criteria:\n\n        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant\n        and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.\n        Acute hepatitis. Other medical condtions that deem participation to be unsafe."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": "90", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000343", 
            "org_study_id": "NIDA-3-0010-8", 
            "secondary_id": "Y01-3-0010-8"
        }, 
        "intervention_browse": {
            "mesh_term": "Central Nervous System Stimulants"
        }, 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90025"
                }, 
                "name": "Friends Research Institute"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Brain Changes in Stimulant Dependent Subjects", 
        "overall_official": {
            "affiliation": "Friends Research Institute, Inc.", 
            "last_name": "Walter Ling, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 4", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000343"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "April 1996", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 1996"
    }, 
    "geocoordinates": {
        "Friends Research Institute": "34.052 -118.244"
    }
}